"Evaluating the efficacy and safety of direct oral anticoagulants compared to warfarin in very morbidly obese patients with non-valvular atrial fibrillation: A retrospective cohort study".

Heliyon · 2025 · PMC11758958 · PMID 39866424

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

• In the comparison of warfarin and DOACs for patients with a BMI ≥50 kg/m 2 , both the one-year and five-year analyses showed consistent trends favoring the use of DOACs over warfarin, although the results did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.